116 related articles for article (PubMed ID: 22265660)
1. Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb.
Glasl L; Kloos K; Giesert F; Roethig A; Di Benedetto B; Kühn R; Zhang J; Hafen U; Zerle J; Hofmann A; de Angelis MH; Winklhofer KF; Hölter SM; Vogt Weisenhorn DM; Wurst W
Exp Neurol; 2012 May; 235(1):214-27. PubMed ID: 22265660
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
[TBL] [Abstract][Full Text] [Related]
3. In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats.
Cai X; Qiao J; Knox T; Iriah S; Kulkarni P; Madularu D; Morrison T; Waszczak B; Hartner JC; Ferris CF
Brain Res; 2019 Mar; 1706():58-67. PubMed ID: 30389398
[TBL] [Abstract][Full Text] [Related]
4. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance.
Heeman B; Van den Haute C; Aelvoet SA; Valsecchi F; Rodenburg RJ; Reumers V; Debyser Z; Callewaert G; Koopman WJ; Willems PH; Baekelandt V
J Cell Sci; 2011 Apr; 124(Pt 7):1115-25. PubMed ID: 21385841
[TBL] [Abstract][Full Text] [Related]
5. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
Kitada T; Pisani A; Porter DR; Yamaguchi H; Tscherter A; Martella G; Bonsi P; Zhang C; Pothos EN; Shen J
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11441-6. PubMed ID: 17563363
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.
Büeler H
Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004
[TBL] [Abstract][Full Text] [Related]
7. Shared and cell type-specific mitochondrial defects and metabolic adaptations in primary cells from PINK1-deficient mice.
Akundi RS; Zhi L; Sullivan PG; Büeler H
Neurodegener Dis; 2013; 12(3):136-49. PubMed ID: 23295771
[TBL] [Abstract][Full Text] [Related]
8. Loss of PINK1 function decreases PP2A activity and promotes autophagy in dopaminergic cells and a murine model.
Qi Z; Yang W; Liu Y; Cui T; Gao H; Duan C; Lu L; Zhao C; Zhao H; Yang H
Neurochem Int; 2011 Oct; 59(5):572-81. PubMed ID: 21672589
[TBL] [Abstract][Full Text] [Related]
9. Silencing of PINK1 induces mitophagy via mitochondrial permeability transition in dopaminergic MN9D cells.
Cui T; Fan C; Gu L; Gao H; Liu Q; Zhang T; Qi Z; Zhao C; Zhao H; Cai Q; Yang H
Brain Res; 2011 Jun; 1394():1-13. PubMed ID: 21262209
[TBL] [Abstract][Full Text] [Related]
10. Genetic mutations and functions of PINK1.
Kawajiri S; Saiki S; Sato S; Hattori N
Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
[TBL] [Abstract][Full Text] [Related]
11. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
Sim CH; Lio DS; Mok SS; Masters CL; Hill AF; Culvenor JG; Cheng HC
Hum Mol Genet; 2006 Nov; 15(21):3251-62. PubMed ID: 17000703
[TBL] [Abstract][Full Text] [Related]
12. Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function.
Xi Y; Ryan J; Noble S; Yu M; Yilbas AE; Ekker M
Eur J Neurosci; 2010 Feb; 31(4):623-33. PubMed ID: 20141529
[TBL] [Abstract][Full Text] [Related]
13. Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages.
Nuber S; Petrasch-Parwez E; Arias-Carrión O; Koch L; Kohl Z; Schneider J; Calaminus C; Dermietzel R; Samarina A; Boy J; Nguyen HP; Teismann P; Velavan TP; Kahle PJ; von Hörsten S; Fendt M; Krüger R; Riess O
Neurobiol Dis; 2011 Nov; 44(2):192-204. PubMed ID: 21767644
[TBL] [Abstract][Full Text] [Related]
14. Loss of PINK1 leads to metabolic deficits in adult neural stem cells and impedes differentiation of newborn neurons in the mouse hippocampus.
Agnihotri SK; Shen R; Li J; Gao X; Büeler H
FASEB J; 2017 Jul; 31(7):2839-2853. PubMed ID: 28325755
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous targeting of centrifugal inputs to the glomerular layer of the main olfactory bulb.
Gómez C; Briñón JG; Barbado MV; Weruaga E; Valero J; Alonso JR
J Chem Neuroanat; 2005 Jun; 29(4):238-54. PubMed ID: 15927786
[TBL] [Abstract][Full Text] [Related]
16. Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms.
Prediger RD
J Alzheimers Dis; 2010; 20 Suppl 1():S205-20. PubMed ID: 20182024
[TBL] [Abstract][Full Text] [Related]
17. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
Gispert S; Ricciardi F; Kurz A; Azizov M; Hoepken HH; Becker D; Voos W; Leuner K; Müller WE; Kudin AP; Kunz WS; Zimmermann A; Roeper J; Wenzel D; Jendrach M; García-Arencíbia M; Fernández-Ruiz J; Huber L; Rohrer H; Barrera M; Reichert AS; Rüb U; Chen A; Nussbaum RL; Auburger G
PLoS One; 2009 Jun; 4(6):e5777. PubMed ID: 19492057
[TBL] [Abstract][Full Text] [Related]
18. PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons.
Wang HL; Chou AH; Wu AS; Chen SY; Weng YH; Kao YC; Yeh TH; Chu PJ; Lu CS
Biochim Biophys Acta; 2011 Jun; 1812(6):674-84. PubMed ID: 21421046
[TBL] [Abstract][Full Text] [Related]
19. Curcumin Rescues a PINK1 Knock Down SH-SY5Y Cellular Model of Parkinson's Disease from Mitochondrial Dysfunction and Cell Death.
van der Merwe C; van Dyk HC; Engelbrecht L; van der Westhuizen FH; Kinnear C; Loos B; Bardien S
Mol Neurobiol; 2017 May; 54(4):2752-2762. PubMed ID: 27003823
[TBL] [Abstract][Full Text] [Related]
20. Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress.
Moisoi N; Fedele V; Edwards J; Martins LM
Neuropharmacology; 2014 Feb; 77():350-7. PubMed ID: 24161480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
